INSIDER · CIK 1738048
Venrock Healthcare Capital Partners III, L.P.
10% Owner at Lycia Therapeutics, Inc. (LYCA)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$37.7MBought on the market
$0.00Sold on the market
1Companies
Oct 27, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202618:38 | Oct 27, 2026from Oct 23, 2026 | LYCALycia Therapeutics, Inc. | 10% Owner | P · Buy | $18.41 | +2,045,440 | 6,825,233 | +43% | +$37.7M | — | +50.6% |
| Oct 27, 202618:38 | Oct 26, 2026 | LYCALycia Therapeutics, Inc. | 10% Owner | C · Convert | — | +4,779,793 | 4,832,732 | +9029% | — |